Document Type : Case-Report

Authors

• Samira Zouhri ¹
• Mohcine El Baroudi ²

¹ University Hassan II of Casablanca

² Hassan II University of Casablanca, Faculty of Sciences Ain chock, Morocco

Abstract

A woman in her sixties with a normal medical history was admitted to a general medical floor with Neuropathic pain symptoms such as a burning sensation throughout her body (head, back, spine, throat, and tongue with dry mouth, chest, abdomen, kidneys, thighs, toes), inability to eat, urinary incontinence, difficulty wearing clothing, and difficulty leaning on the back. There was a difficulty and delay in diagnosing the patient's condition, which was confirmed to have severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with no respiratory symptoms. The patient's pain did not respond to the covid-19's first-line medications, but it did respond to neuropathic medication with Pregabalin and Alprazolam. Our study shows that Pregabalin could be helpful in relieving the patient’s pain and very effective for treating neuropathic pain with a safe profile, unlike Alprazolam, which interferes with the same stages of sleep, which made her sleep condition worse.

Keywords

• Alprazolam
• Covid-19
• Neuropathic pain
• Pregabalin
• SARS-CoV-2
• Morocco
• Case-report
• Clinical

Main Subjects

• COVID-19